This inventor holds 1 USPTO granted patent. Top assignee: Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.v.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mirko Buchholz: Innovator in Tetracycline Complexes
Introduction
Mirko Buchholz is a notable inventor based in Halle, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tetracycline complexes with sustained activity. His work focuses on enhancing the effectiveness of antibiotic treatments.
Latest Patents
Mirko Buchholz holds a patent for "Tetracycline complexes with sustained activity." This invention relates to the controlled release of tetracycline antibiotics. Specifically, it involves a complex comprising a tetracycline compound or a pharmaceutically acceptable salt, hydrate, or solvate thereof, along with a divalent metal carboxylate. The patent outlines a pharmaceutical preparation that includes this complex, methods for manufacturing it, and its application in treating bacterial infections. The invention aims to maintain antibiotic activity over a prolonged period, particularly for the therapy and prophylaxis of acute, chronic, or recurrent periodontal disease. He has 1 patent to his name.
Career Highlights
Mirko Buchholz is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in applied sciences. His work at this institution has allowed him to focus on innovative solutions in the pharmaceutical sector.
Collaborations
Throughout his career, Mirko has collaborated with notable colleagues, including Martin Kirchberg and Sigrun Eick. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Mirko Buchholz is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on tetracycline complexes. His contributions have the potential to significantly impact antibiotic therapy and improve treatment outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile